Boston Scientific Beefs Up Endosurgery Unit With Enteric Medical
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific appears to be hedging against uncertainties in its Scimed interventional cardiology business by strengthening its product pipeline in other units, particularly its Endosurgery group